Aarti Pharmalabs Limited
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Aarti Pharmalabs Limited generated cash of $2,163,546,000, which is less than the previous year. Cash used in financing activities reached the amount of $97,235,000 last year. Net change in cash is therefore $115,137,000.

Cash Flow

Aarti Pharmalabs Limited (NSE:AARTIPHARM.NS): Cash Flow
2020 -186.75K 0 2.68M
2021 0 0 0
2023 2.63B -1.57B -1.63B
2024 2.16B -2.14B 97.23M

AARTIPHARM.NS Cash Flow Statement (2019 – 2023)

2023 2022 2020 2019
Cash at beginning of period
121.21M832.7M2.5M0
Operating activities
Net income
2.16B2.60B-45.96K-186.75K
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
732.35M625.4M00
Stock-based compensation expense
2.28M000
Deferred income tax benefit 2.28M000
Changes in operating assets and liabilities:
Accounts receivable, net
-1.25B-207.59M46K0
Inventories
-396.6M-1.26B00
Accounts payable
433.5M1.30B00
Cash generated by operating activities
2.16B2.63B0-186.75K
Investing activities
Purchases Of Investments
-194.03M-391.23M00
Investments In Property Plant And Equipment
-1.55B-1.19B00
Acquisitions Net
0000
Cash generated by investing activities
-2.14B-1.57B00
Financing activities
Common Stock Issued
0000
Payments for dividends
-181.25M-181.25M00
Repurchases of common stock
0000
Repayments of term debt
499.93M-1.24B00
Cash used in financing activities
97.23M-1.63B02.68M
Net Change In Cash
115.13M-582.7M02.5M
Cash at end of period
236.34M250M2.5M2.5M
Data sourceData sourceData sourceData source